← FDA Drug Approvals (Drugs@FDA)

EPCLUSA

NDA · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2021-06-10

Drug application

FDA Application #

NDA214187

Application type

New Drug Application

Brand name

EPCLUSA

Generic name

VELPATASVIR AND SOFOSBUVIR

Active ingredients

SOFOSBUVIR; VELPATASVIR

Dosage form

PELLETS

Route

ORAL

Marketing status

Prescription

Sponsor

GILEAD SCIENCES INC

Manufacturer

Gilead Sciences, Inc.

First approval

2021-06-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown